PRAXIS Resource Repository Search our extensive library of COPD care and readmissions reduction resources, including best practices, research articles, educational materials and toolkits.
Return to all articles Return to previous page Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD Resource Type: Research Papers 0 Comments | 1 Likes The COPD Biomarkers Qualification Consortium (CBQC) is a partnership between the COPD Foundation, the U.S. Food and Drug Administration (FDA) and the pharmaceutical industry developed in part to demonstrate that individual biomarkers can be used effectively in the drug development process. This paper presents the process and outcomes of a project seeking approval of fibrinogen, a measure of inflammation, as a biomarker for use in clinical COPD trials. View Resource Citation: Mannino DM, Tal-Singer R, Lomas DA, et al. Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD. J COPD F. 2015; 2(1): 23-34. http://journal.copdfoundation.org/jcopdf/id/1043/Plasma-Fibrinogen-as-a-Biomarker-for-Mortality-and-Hospitalized-Exacerbations-in-People-with-COPD. exacerbations hospitalization No Comments You need to login to comment.
Return to all articles Return to previous page Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD Resource Type: Research Papers 0 Comments | 1 Likes The COPD Biomarkers Qualification Consortium (CBQC) is a partnership between the COPD Foundation, the U.S. Food and Drug Administration (FDA) and the pharmaceutical industry developed in part to demonstrate that individual biomarkers can be used effectively in the drug development process. This paper presents the process and outcomes of a project seeking approval of fibrinogen, a measure of inflammation, as a biomarker for use in clinical COPD trials. View Resource Citation: Mannino DM, Tal-Singer R, Lomas DA, et al. Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD. J COPD F. 2015; 2(1): 23-34. http://journal.copdfoundation.org/jcopdf/id/1043/Plasma-Fibrinogen-as-a-Biomarker-for-Mortality-and-Hospitalized-Exacerbations-in-People-with-COPD. exacerbations hospitalization No Comments You need to login to comment.
Type of Resource View All Articles Articles (46) Case Studies (17) Educational Materials (14) Opinion/Editorials (11) Policy Statements (3) Presentations (11) Research Papers (83) Statistics (12) Toolkits (33) Webinars (12) White Papers/Reports (14)
Tags View All Articles 122readmission105hospitalization85treatment84patient education78care coordination78promising practices75evaluation & quality improvement68patient experience61exacerbations55post-acute care54caregiver & community54co-morbidities53telehealth41risk stratification39pulmonary rehabilitation38behavioral health37diagnosis34public policy32ambulatory care31prevention23oxygen23HRRP22socioeconomic issues18Palliative care15exercise11nutrition6Alpha-15hospice3quality improvement1research & quality improvement1hospitalizations